Mylan Pharmaceuticals Inc clinical trials

Acquired by Viatris Inc., Nov 16, 2020 · source ↗

The registry lists 160 studies whose lead sponsor is Mylan Pharmaceuticals Inc. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 160. List all 160 → · All Viatris Inc. studies →

• Investigating Ovulation Inhibition for Use as a ContraceptiveRecruitingNCT07365904Phase 2

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted after Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing PotentialActive, not recruitingNCT06672016Phase 3

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted after Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Extension Study of MYL-1701P-3001 for Safety and EfficacyCompletedNCT04674800Phase 3

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted after Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Dose-finding Study of MR-130A-01 Contraceptive Transdermal PatchCompletedNCT06048536Phase 2

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted after Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mgCompletedNCT00650273Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fed Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mgCompletedNCT00648765Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate TabletsCompletedNCT00650520Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcgCompletedNCT00648882Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mgCompletedNCT00648427Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mgCompletedNCT00649129Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mgCompletedNCT00648791Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Fexofenadine Tablets 180 mg and Allegra® Tablets 180 mgCompletedNCT00649376Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mgCompletedNCT00649480Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mgCompletedNCT00649662Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mgCompletedNCT00648531Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mgCompletedNCT00649194Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Doxycycline Monohydrate Tablets 100 mg and Adoxa Tablets 100 mgCompletedNCT00648180Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mgCompletedNCT00647894Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mgCompletedNCT00648362Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mgCompletedNCT00648557Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mgCompletedNCT00650065Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Comparative Bioavailability Study of Clarithromycin 250 mg TabletsCompletedNCT00648830Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mgCompletedNCT00649155Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μgCompletedNCT00647855Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mgCompletedNCT00649350Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mgCompletedNCT00649168Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mgCompletedNCT00648440Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fed, Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In SubjectsCompletedNCT00648544Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mgCompletedNCT00648401Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mgCompletedNCT00648492Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mgCompletedNCT00648804Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mgCompletedNCT00649857Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mgCompletedNCT00650325Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mgCompletedNCT00649948Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fed Study of Azithromycin Tablets 600 mg to Zithromax® Tablets 600 mgCompletedNCT00649935Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Ondansetron Orally Disintegrating Tablets 8 mg to Zofran ODT® Tablets 8 mgCompletedNCT00649363Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mgCompletedNCT00650416Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mgCompletedNCT00649558Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mgCompletedNCT00649324Early Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mgCompletedNCT00650286Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mgCompletedNCT00650169Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mgCompletedNCT00650481Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mgCompletedNCT00647881Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mgCompletedNCT00650312Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mgCompletedNCT00649181Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mgCompletedNCT00649272Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mgCompletedNCT00648050Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mgCompletedNCT00650195Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mgCompletedNCT00649012Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.

• Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting StateCompletedNCT00647738Phase 1

  Sponsor listed in the registry: Mylan Pharmaceuticals Inc · First submitted before Mylan Pharmaceuticals Inc became part of Viatris Inc.